Liangpeng Yang

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Squamous Cell Carcinoma

Transforming Growth Factor

Radiation Induced

Top Venues

Cancer research

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Phillip M Pifer, Liangpeng Yang, Manish Kumar, Tongxin Xie, Mitchell J Frederick, Andrew Hefner, Beth M Beadle, David P Molkentine, Jessica M Molkentine, Annika Dhawan, Mohamed K Abdelhakiem, Abdullah A Osman, Brian J Leibowitz, Jeffrey N Myers, Curtis R Pickering, Vlad C Sandulache, John Victor Heymach, Heath D Skinner
FAK drives resistance to therapy in HPV-negative head and neck cancer in a p53-dependent manner. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Kewen He, Hampartsoum B Barsoumian, Nahum Puebla-Osorio, Yun Hu, Duygu Sezen, Mark D Wasley, Genevieve Bertolet, Jie Zhang, Carola Leuschner, Liangpeng Yang, Claudia S Kettlun Leyton, Natalie Wall Fowlkes, Morgan Maureen Green, Lisa Hettrick, Dawei Chen, Fatemeh Masropour, Meidi Gu, Hadi Maazi, Alexey S Revenko, Maria Angelica Cortez, James W Welsh
Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti-PD1 in Metastatic Non-Small Cell Lung Cancer. Cancer immunology research (2023)
David P Molkentine, Jessica M Molkentine, Kathleen A Bridges, David R Valdecanas, Annika Dhawan, Reshub Bahri, Andrew J Hefner, Manish Kumar, Liangpeng Yang, Mohamed K Abdelhakiem, Phillip M Pifer, Vlad Sandulache, Aakash Sheth, Beth M Beadle, Howard D Thames, Kathryn A Mason, Curtis R Pickering, Raymond E Meyn, Heath D Skinner
p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade. Cancer research 82 (5) (2022)
Manish Kumar, David P Molkentine, Jessica M Molkentine, Kathleen Bridges, Tongxin Xie, Liangpeng Yang, Andrew Hefner, Meng Gao, Reshub Bahri, Annika Dhawan, Mitchell J Frederick, Sahil B Seth, Mohamed K Abdelhakiem, Beth M Beadle, Faye M Johnson, Jing Wang, Li Shen, Timothy P Heffernan, Aakash Sheth, Robert L Ferris, Jeffrey N Myers, Curtis R Pickering, Heath D Skinner
Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function. Nature communications 12 (1) (2021)